Abstract
Microplasma-based drug delivery, particularly transdermal drug delivery, has emerged as a promising alternatives to conventional methods due to its unique advantages. In this system, plasma components interact not only with the stratum corneum but also with the cells beneath it. Cell membranes mainly comprise lipids which are highly susceptible to plasma components, including reactive oxygen and nitrogen species. However, the effects of microplasma irradiation on cell membrane lipids are largely unexplored. In this context, the current study investigated an important physical property of cell membranes, membrane lipid order, in small intestinal epithelial cells after microplasma irradiation. First, the microplasma irradiation condition was optimized for the intracellular delivery of high molecular weight molecules, namely fluorescein isothiocyanate-dextran (FD-150 and FD-2000). Air microplasma discharge was applied at varying voltages (i.e., 3.5, 4.0, and 4.5 kV), and the efficiency of drug absorption was evaluated using a microplate reader and a fluorescence microscope. The cell viability was calculated using an automated cell counter. The most favorable outcomes in terms of both drug absorption and cell viability were achieved at 4 kV. Next, the membrane lipid order of cells was investigated using a solvatochromic dye after microplasma irradiation at 4 kV. Interestingly, non-irradiated cells exclusively manifested the liquid-ordered phase, whereas irradiated cells displayed a dual-phased composition comprising both liquid-ordered and liquid-disordered phases. In addition, live-cell imaging unveiled that alterations in membrane lipid order commenced as early as 4 min post-irradiation. This evidence points to a significant reduction in lipid packing and membrane thickness induced by microplasma irradiation. The findings shed light on the intricate mechanism underlying cellular drug absorption facilitated by microplasma irradiation. The insights gained into the impact on membrane lipid properties will contribute to developing safe and efficient drug delivery systems while minimizing side effects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.